SlideShare a Scribd company logo
Under the guidance of: Submitted by:
Dr. G. Ramesh G.Manoj sai
14AB1T0009
DEFINITION:
 Newsletter is a bulletin issued periodically to the
member of society , business or organisation
(HOSPITALS)
AIMS:
 For the transmission of information
 To communicate the decisions made by the PTC
FOR TRANSMISSION OF INFORMATION:
 Latest information in medical sciences
 Newly introduced drugs
 Newly introduced indicate
 New drug delivery systems
 Update on drug interactions & ADR’s
 Drug therapy guideline development
 Medication safety information / precautions
---Information to physicians nurses and other nursing staff
for public relations
TO COMMUNICATE DECISIONSMADE BY PTC:
 Use policy
 Revising drug formulary
 ADR monitoring programmes
 Drug product defect reporting programmes
 Drug utilisation review
LAYOUT FOR NEWS LETTER:
 Selection of the title
 Contents of the news letter
 Format and printing
 Distribution
 Advantages
1.Selection of the title:
 The title should be specific (clear) & unique
 EX: Title like pharmacy review, Pharmacy
news bulletin,and pharma times
2. Contents of the Newsletter:
 Editorial column
 New drug selection
 Abstract
 Medical staff
 New discoveries & Delivery systems
3. Format and printing:
 Structure of bulletin varies with organisation of pharmacist
 The publication is printed in ROYAL BOND paper
measuring size of 8.5-11 inches
 4.Distribution:
 Distribution Through
 Medical staff
 Library
 Administrative block
 Nursing services
 Laboratories may always send a pharmacy publication
5. Advantages:
 Although preparation of such news bulletin requires time
with a lot of information in news bulletin. This means better
communication compared to Telephone and verbal
communication
MAKING YOUR NEWS LETTER LOOK ATTRACTIVE:
 The layout of newsletter should be simple and make it
easy to navigate
 Create a title that brands your newsletter& use it for
every issue
 Any pictures used should have a professional quality
to them& fit with your company’s overall image
 If the product or service merits greater coverage break
it up into several chunks
 Try to keep paragraphs b/w 50-125 words & articles
fewer than 800 words.
REFERRENCES
 1.A textbook of Hospital pharmacy by Goyal.
 2. https://www.tg.org.au/
 3.https://www.clinicalguidelines.gov.au/port
al/2406/therapeutic-guidelines-antibiotic-
version-15
14ab1t0009    newsletter

More Related Content

What's hot

Drug induced liver disorders for Pharm.D
Drug induced liver disorders for Pharm.DDrug induced liver disorders for Pharm.D
Drug induced liver disorders for Pharm.D
Soujanya Pharm.D
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
Dr. Ramesh Bhandari
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
Dr. Ramesh Bhandari
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
Rafi Bhat
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Anjali Rarichan
 
14ab1 t0011 professional relations and practices of hospital pharmacy
14ab1 t0011  professional relations and practices of hospital pharmacy14ab1 t0011  professional relations and practices of hospital pharmacy
14ab1 t0011 professional relations and practices of hospital pharmacy
Ramesh Ganpisetti
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
Dr. Ramesh Bhandari
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
maneeshkumar reddy
 
Role of the pharmacist in medication safety.
Role of the pharmacist in medication safety.Role of the pharmacist in medication safety.
Role of the pharmacist in medication safety.
Subash321
 
Ward round participation
Ward round participationWard round participation
Ward round participation
Dr. Ramesh Bhandari
 
Establishing a drug information center
Establishing a drug information centerEstablishing a drug information center
Establishing a drug information center
katta amulya
 
14ab1t0017 procurement and warehousing of radiopharmaceuticals
14ab1t0017   procurement and warehousing of radiopharmaceuticals14ab1t0017   procurement and warehousing of radiopharmaceuticals
14ab1t0017 procurement and warehousing of radiopharmaceuticals
Ramesh Ganpisetti
 
7 continuing professional development programs
7 continuing professional development programs7 continuing professional development programs
7 continuing professional development programs
Chanukya Vanam . Dr
 
Bioavailability testing protocol
Bioavailability testing protocolBioavailability testing protocol
Bioavailability testing protocol
Annapureddy Thirupathireddy
 
Budget preparation & implementation
Budget preparation & implementationBudget preparation & implementation
Budget preparation & implementation
Dr Manish Pal Singh
 
14ab1 t0004 therapeutic guidelines
14ab1 t0004  therapeutic guidelines14ab1 t0004  therapeutic guidelines
14ab1 t0004 therapeutic guidelines
Ramesh Ganpisetti
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical careAkram Ahmad
 
medication adherence
medication adherencemedication adherence
medication adherence
Ramesh Ganpisetti
 
pharmaceutical care
pharmaceutical carepharmaceutical care
pharmaceutical care
Dr Arathy R Nath
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdf
Ameena Kadar
 

What's hot (20)

Drug induced liver disorders for Pharm.D
Drug induced liver disorders for Pharm.DDrug induced liver disorders for Pharm.D
Drug induced liver disorders for Pharm.D
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
 
14ab1 t0011 professional relations and practices of hospital pharmacy
14ab1 t0011  professional relations and practices of hospital pharmacy14ab1 t0011  professional relations and practices of hospital pharmacy
14ab1 t0011 professional relations and practices of hospital pharmacy
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Role of the pharmacist in medication safety.
Role of the pharmacist in medication safety.Role of the pharmacist in medication safety.
Role of the pharmacist in medication safety.
 
Ward round participation
Ward round participationWard round participation
Ward round participation
 
Establishing a drug information center
Establishing a drug information centerEstablishing a drug information center
Establishing a drug information center
 
14ab1t0017 procurement and warehousing of radiopharmaceuticals
14ab1t0017   procurement and warehousing of radiopharmaceuticals14ab1t0017   procurement and warehousing of radiopharmaceuticals
14ab1t0017 procurement and warehousing of radiopharmaceuticals
 
7 continuing professional development programs
7 continuing professional development programs7 continuing professional development programs
7 continuing professional development programs
 
Bioavailability testing protocol
Bioavailability testing protocolBioavailability testing protocol
Bioavailability testing protocol
 
Budget preparation & implementation
Budget preparation & implementationBudget preparation & implementation
Budget preparation & implementation
 
14ab1 t0004 therapeutic guidelines
14ab1 t0004  therapeutic guidelines14ab1 t0004  therapeutic guidelines
14ab1 t0004 therapeutic guidelines
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
medication adherence
medication adherencemedication adherence
medication adherence
 
pharmaceutical care
pharmaceutical carepharmaceutical care
pharmaceutical care
 
poison and drug info.pdf
poison and drug info.pdfpoison and drug info.pdf
poison and drug info.pdf
 

Similar to 14ab1t0009 newsletter

HOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptxHOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptx
Archana Chavhan
 
Promotional drug literature
Promotional drug literature  Promotional drug literature
Promotional drug literature
bhagyamohod90
 
Beyond asthma and COPD | Insight, issue 2
Beyond asthma and COPD | Insight, issue 2Beyond asthma and COPD | Insight, issue 2
Beyond asthma and COPD | Insight, issue 2Team Consulting Ltd
 
Customer Experience (CX) in Physician and HCP Engagement
Customer Experience (CX) in Physician and HCP EngagementCustomer Experience (CX) in Physician and HCP Engagement
Customer Experience (CX) in Physician and HCP Engagement
MarketResearch.com
 
Pharmacy practice research and competitive advantage theory
Pharmacy practice research and competitive advantage theoryPharmacy practice research and competitive advantage theory
Pharmacy practice research and competitive advantage theory
Virginia Commonwealth University School of Pharmacy
 
d'ambruso, caron resume 1.2 2015
d'ambruso, caron  resume 1.2  2015d'ambruso, caron  resume 1.2  2015
d'ambruso, caron resume 1.2 2015Caron D'Ambruso
 
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
AmeetRathod3
 
Drug information Services.pptx
Drug information Services.pptxDrug information Services.pptx
Drug information Services.pptx
Dr.Navaneethakrishnan S
 
Project description future challenges and focus group on pharmaceutical suppl...
Project description future challenges and focus group on pharmaceutical suppl...Project description future challenges and focus group on pharmaceutical suppl...
Project description future challenges and focus group on pharmaceutical suppl...
Dr. Hannes Hofmann
 
Pharmaceutical Management: Product mix
Pharmaceutical Management: Product mixPharmaceutical Management: Product mix
Pharmaceutical Management: Product mix
Carmela Alonzo
 
Five Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' StrategyFive Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' Strategy
executiveinsight
 
Sales & Marketing Optimization in Oncology
Sales & Marketing Optimization in OncologySales & Marketing Optimization in Oncology
Sales & Marketing Optimization in OncologyThe MarkeTech Group
 
Developing a pharmaceutical income generating business within synapse services
Developing a pharmaceutical income generating business within synapse servicesDeveloping a pharmaceutical income generating business within synapse services
Developing a pharmaceutical income generating business within synapse services
Okhuosami Fatima
 
2011_10_20_slide-deck_AZ_SB6
2011_10_20_slide-deck_AZ_SB62011_10_20_slide-deck_AZ_SB6
2011_10_20_slide-deck_AZ_SB6Dr. Stefan Busch
 
SampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App ChallengeSampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App Challengejakehalpert
 
Marketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA ProgramMarketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA Program
jreidglass1
 
Assured Pharmacy Investor Presentation 052510
Assured Pharmacy Investor Presentation 052510Assured Pharmacy Investor Presentation 052510
Assured Pharmacy Investor Presentation 052510
Assured Pharmacy, Inc.
 
Strategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisStrategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi Aventis
Bruno Rakotozafy
 

Similar to 14ab1t0009 newsletter (20)

HOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptxHOSPITAL FORMULARY.pptx
HOSPITAL FORMULARY.pptx
 
Promotional drug literature
Promotional drug literature  Promotional drug literature
Promotional drug literature
 
3
33
3
 
Beyond asthma and COPD | Insight, issue 2
Beyond asthma and COPD | Insight, issue 2Beyond asthma and COPD | Insight, issue 2
Beyond asthma and COPD | Insight, issue 2
 
imprex
impreximprex
imprex
 
Customer Experience (CX) in Physician and HCP Engagement
Customer Experience (CX) in Physician and HCP EngagementCustomer Experience (CX) in Physician and HCP Engagement
Customer Experience (CX) in Physician and HCP Engagement
 
Pharmacy practice research and competitive advantage theory
Pharmacy practice research and competitive advantage theoryPharmacy practice research and competitive advantage theory
Pharmacy practice research and competitive advantage theory
 
d'ambruso, caron resume 1.2 2015
d'ambruso, caron  resume 1.2  2015d'ambruso, caron  resume 1.2  2015
d'ambruso, caron resume 1.2 2015
 
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
 
Drug information Services.pptx
Drug information Services.pptxDrug information Services.pptx
Drug information Services.pptx
 
Project description future challenges and focus group on pharmaceutical suppl...
Project description future challenges and focus group on pharmaceutical suppl...Project description future challenges and focus group on pharmaceutical suppl...
Project description future challenges and focus group on pharmaceutical suppl...
 
Pharmaceutical Management: Product mix
Pharmaceutical Management: Product mixPharmaceutical Management: Product mix
Pharmaceutical Management: Product mix
 
Five Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' StrategyFive Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' Strategy
 
Sales & Marketing Optimization in Oncology
Sales & Marketing Optimization in OncologySales & Marketing Optimization in Oncology
Sales & Marketing Optimization in Oncology
 
Developing a pharmaceutical income generating business within synapse services
Developing a pharmaceutical income generating business within synapse servicesDeveloping a pharmaceutical income generating business within synapse services
Developing a pharmaceutical income generating business within synapse services
 
2011_10_20_slide-deck_AZ_SB6
2011_10_20_slide-deck_AZ_SB62011_10_20_slide-deck_AZ_SB6
2011_10_20_slide-deck_AZ_SB6
 
SampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App ChallengeSampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App Challenge
 
Marketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA ProgramMarketing Presentation For 2011 MBA Program
Marketing Presentation For 2011 MBA Program
 
Assured Pharmacy Investor Presentation 052510
Assured Pharmacy Investor Presentation 052510Assured Pharmacy Investor Presentation 052510
Assured Pharmacy Investor Presentation 052510
 
Strategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisStrategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi Aventis
 

More from Ramesh Ganpisetti

PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
Ramesh Ganpisetti
 
A. SUJATHA
A. SUJATHAA. SUJATHA
A. SUJATHA
Ramesh Ganpisetti
 
VELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAIVELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAI
Ramesh Ganpisetti
 
UNNAM VENKATESWARLU
UNNAM VENKATESWARLUUNNAM VENKATESWARLU
UNNAM VENKATESWARLU
Ramesh Ganpisetti
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
Ramesh Ganpisetti
 
RAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAMRAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAM
Ramesh Ganpisetti
 
P. MERIKUMARI
P. MERIKUMARIP. MERIKUMARI
P. MERIKUMARI
Ramesh Ganpisetti
 
NARISETTI SINDURA
NARISETTI SINDURANARISETTI SINDURA
NARISETTI SINDURA
Ramesh Ganpisetti
 
M. SRUJANA
M. SRUJANAM. SRUJANA
M. SRUJANA
Ramesh Ganpisetti
 
kamma sri pandu mukharjee
kamma sri pandu mukharjeekamma sri pandu mukharjee
kamma sri pandu mukharjee
Ramesh Ganpisetti
 
J. SUBRAHMANYAM
J. SUBRAHMANYAMJ. SUBRAHMANYAM
J. SUBRAHMANYAM
Ramesh Ganpisetti
 
KHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSANKHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSAN
Ramesh Ganpisetti
 
DASARI NIROOSHA
DASARI NIROOSHADASARI NIROOSHA
DASARI NIROOSHA
Ramesh Ganpisetti
 
KOTHA BHUVANESWARI
KOTHA BHUVANESWARIKOTHA BHUVANESWARI
KOTHA BHUVANESWARI
Ramesh Ganpisetti
 
V. SIVANI
V. SIVANIV. SIVANI
R. SAI YAMINI
R. SAI YAMINIR. SAI YAMINI
R. SAI YAMINI
Ramesh Ganpisetti
 
INDU
INDUINDU
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
Ramesh Ganpisetti
 
A.sai sivani
A.sai sivaniA.sai sivani
A.sai sivani
Ramesh Ganpisetti
 
V. RAGINI
V. RAGINIV. RAGINI

More from Ramesh Ganpisetti (20)

PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
 
A. SUJATHA
A. SUJATHAA. SUJATHA
A. SUJATHA
 
VELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAIVELAVARTHIPATI PRUDHVI SAI
VELAVARTHIPATI PRUDHVI SAI
 
UNNAM VENKATESWARLU
UNNAM VENKATESWARLUUNNAM VENKATESWARLU
UNNAM VENKATESWARLU
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
 
RAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAMRAGAM SWETHA SAMRAJYAM
RAGAM SWETHA SAMRAJYAM
 
P. MERIKUMARI
P. MERIKUMARIP. MERIKUMARI
P. MERIKUMARI
 
NARISETTI SINDURA
NARISETTI SINDURANARISETTI SINDURA
NARISETTI SINDURA
 
M. SRUJANA
M. SRUJANAM. SRUJANA
M. SRUJANA
 
kamma sri pandu mukharjee
kamma sri pandu mukharjeekamma sri pandu mukharjee
kamma sri pandu mukharjee
 
J. SUBRAHMANYAM
J. SUBRAHMANYAMJ. SUBRAHMANYAM
J. SUBRAHMANYAM
 
KHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSANKHANDEKER FATIMA FARAH HASSAN
KHANDEKER FATIMA FARAH HASSAN
 
DASARI NIROOSHA
DASARI NIROOSHADASARI NIROOSHA
DASARI NIROOSHA
 
KOTHA BHUVANESWARI
KOTHA BHUVANESWARIKOTHA BHUVANESWARI
KOTHA BHUVANESWARI
 
V. SIVANI
V. SIVANIV. SIVANI
V. SIVANI
 
R. SAI YAMINI
R. SAI YAMINIR. SAI YAMINI
R. SAI YAMINI
 
INDU
INDUINDU
INDU
 
DINDI.SANDHYA RANI
DINDI.SANDHYA RANIDINDI.SANDHYA RANI
DINDI.SANDHYA RANI
 
A.sai sivani
A.sai sivaniA.sai sivani
A.sai sivani
 
V. RAGINI
V. RAGINIV. RAGINI
V. RAGINI
 

Recently uploaded

The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 

Recently uploaded (20)

The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 

14ab1t0009 newsletter

  • 1. Under the guidance of: Submitted by: Dr. G. Ramesh G.Manoj sai 14AB1T0009
  • 2. DEFINITION:  Newsletter is a bulletin issued periodically to the member of society , business or organisation (HOSPITALS) AIMS:  For the transmission of information  To communicate the decisions made by the PTC
  • 3. FOR TRANSMISSION OF INFORMATION:  Latest information in medical sciences  Newly introduced drugs  Newly introduced indicate  New drug delivery systems  Update on drug interactions & ADR’s  Drug therapy guideline development  Medication safety information / precautions ---Information to physicians nurses and other nursing staff for public relations
  • 4. TO COMMUNICATE DECISIONSMADE BY PTC:  Use policy  Revising drug formulary  ADR monitoring programmes  Drug product defect reporting programmes  Drug utilisation review LAYOUT FOR NEWS LETTER:  Selection of the title  Contents of the news letter  Format and printing  Distribution  Advantages
  • 5. 1.Selection of the title:  The title should be specific (clear) & unique  EX: Title like pharmacy review, Pharmacy news bulletin,and pharma times 2. Contents of the Newsletter:  Editorial column  New drug selection  Abstract  Medical staff  New discoveries & Delivery systems
  • 6. 3. Format and printing:  Structure of bulletin varies with organisation of pharmacist  The publication is printed in ROYAL BOND paper measuring size of 8.5-11 inches  4.Distribution:  Distribution Through  Medical staff  Library  Administrative block  Nursing services  Laboratories may always send a pharmacy publication 5. Advantages:  Although preparation of such news bulletin requires time with a lot of information in news bulletin. This means better communication compared to Telephone and verbal communication
  • 7. MAKING YOUR NEWS LETTER LOOK ATTRACTIVE:  The layout of newsletter should be simple and make it easy to navigate  Create a title that brands your newsletter& use it for every issue  Any pictures used should have a professional quality to them& fit with your company’s overall image  If the product or service merits greater coverage break it up into several chunks  Try to keep paragraphs b/w 50-125 words & articles fewer than 800 words.
  • 8.
  • 9. REFERRENCES  1.A textbook of Hospital pharmacy by Goyal.  2. https://www.tg.org.au/  3.https://www.clinicalguidelines.gov.au/port al/2406/therapeutic-guidelines-antibiotic- version-15